Duvortuxizumab (INN) is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies. This drug was developed by Janssen Global…
Duvortuxizumab (INN) is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies.
This drug was developed by Janssen Global Services.Statement On A Nonproprietary Name Adopted By The USAN Council - Duvortuxizumab, American Medical Association.
References
Gebaseerd op: Wikipedia — Duvortuxizumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.